Showing results (2011-2020 of 2,029) with videos related to
Sort By:
Pageof 203
Journal of Medicinal Chemistry|February 2, 2023
Discovery of a Potent and Orally Bioavailable Zwitterionic Series of Selective Estrogen Receptor Degrader-AntagonistsJames S Scott, Darren Stead, Bernard Barlaam, et al.Nature Medicine|June 8, 2023
Integrated multi-omics for rapid rare disease diagnosis on a national scaleSebastian Lunke, Sophie E Bouffler, Chirag V Patel, et al.Journal of Medicinal Chemistry|September 10, 2020
Discovery of AZD9833, a Potent and Orally Bioavailable Selective Estrogen Receptor Degrader and AntagonistJames S Scott, Thomas A Moss, Amber Balazs, et al.Nature Genetics|March 31, 2019
Genomic subtyping and therapeutic targeting of acute erythroleukemiaIlaria Iacobucci, Ji Wen, Manja Meggendorfer, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|September 30, 2008
The synthesis of azadirachtin: a potent insect antifeedantSteven V Ley, Antonio Abad-Somovilla, James C Anderson, et al.Cell|September 11, 2021
Emergence of an early SARS-CoV-2 epidemic in the United StatesMark Zeller, Karthik Gangavarapu, Catelyn Anderson, et al.Medrxiv : the Preprint Server for Health Sciences|February 10, 2021
Emergence of an early SARS-CoV-2 epidemic in the United StatesMark Zeller, Karthik Gangavarapu, Catelyn Anderson, et al.Blood|July 11, 2024
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionJiarna R Zerella, Claire C Homan, Peer Arts, et al.Blood Advances|March 26, 2020
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AMLAnna L Brown, Peer Arts, Catherine L Carmichael, et al.American Journal of Human Genetics|March 3, 2023
Australian Genomics: Outcomes of a 5-year national program to accelerate the integration of genomics in healthcareZornitza Stark, Tiffany Boughtwood, Matilda Haas, et al.Pageof 203